MedPage Today -- HOUSTON, May 15 -- An antiviral drug that targets a growth-promoting oncogene led to stable disease or better response in all but two patients with relapsed or refractory acute myeloid leukemia in a small Canadian study.
MedPage Today -- HOUSTON, May 15 -- An antiviral drug that targets a growth-promoting oncogene led to stable disease or better response in all but two patients with relapsed or refractory acute myeloid leukemia in a small Canadian study.